Skip to main content
Top
Published in: Annals of Hematology 4/2019

01-04-2019 | Original Article

Role of platelets in thrombin generation amongst patients with non-transfusion-dependent thalassaemia

Authors: Chuen Wen Tan, Wan Hui Wong, Roserahayu Idros, Yiong Huak Chan, Hartirathpal Kaur, Alvin Ren Kwang Tng, Lai Heng Lee, Heng Joo Ng, Ai Leen Ang

Published in: Annals of Hematology | Issue 4/2019

Login to get access

Abstract

Non-transfusion-dependent thalassaemia (NTDT) is associated with a hypercoagulable state with thrombotic risk highest after splenectomy. Various mechanisms have been proposed. Although an antiplatelet agent is commonly recommended as thromboprophylaxis in NTDT, the role of platelets contributing to this hypercoagulable state is not well-defined. This study aims to evaluate the role of platelets contributing to hypercoagulability in NTDT patients using thrombin generation (TG). Platelet-rich (PRP) and platelet-poor plasma (PPP) were collected from NTDT patients (n = 30) and normal controls (n = 20) for TG measurement and compared. Controls had higher endogenous thrombin potential (ETP) in PPP (1204.97 nM.min vs 911.62 nM.min, p < 0.001) and PRP (1424.23 nM.min vs 983.99 nM.min, p < 0.001) than patients. Patients’ mean normalized ETP ratio [{PRP ETP (patient)/PPP ETP (patient)}/{mean PPP ETP (controls)/mean PPP ETP (controls)}], demonstrated that the presence of platelet does not alter ETP (mean ratio 0.97, 95% CI 0.93–1.02, equivalence defined as 10%). Types of thalassaemia, splenectomy, and severity of liver iron overload did not significantly influence patients’ ETP in PPP and PRP by multivariate analysis. Platelets did not increase the TG potential of NTDT patients. Instead of being hypercoagulable, our NTDT patients were hypocoagulable by ETP measurement, although this could not be conclusively demonstrated to correlate with their iron overloading state giving rise to reduced synthesis of coagulation factors. The guideline recommendations for thromboprophylaxis with antiplatelet agents in similar NTDT patients should be re-examined.
Literature
1.
2.
go back to reference Taher A, Isma’eel H, Mehio G, Bignamini D, Kattamis A, Rachmilewitz E, Cappellini M (2006) Prevalence of thromboembolic events among 8,860 patients with thalassaemia major and intermedia in the Mediterranean area and Iran. Thromb Haemost 96:488–491CrossRefPubMed Taher A, Isma’eel H, Mehio G, Bignamini D, Kattamis A, Rachmilewitz E, Cappellini M (2006) Prevalence of thromboembolic events among 8,860 patients with thalassaemia major and intermedia in the Mediterranean area and Iran. Thromb Haemost 96:488–491CrossRefPubMed
3.
go back to reference Musallam KM, Taher AT (2011) Thrombosis in thalassemia: why are we so concerned? Hemoglobin 35:503–510CrossRefPubMed Musallam KM, Taher AT (2011) Thrombosis in thalassemia: why are we so concerned? Hemoglobin 35:503–510CrossRefPubMed
4.
go back to reference Cappellini MD, Robbiolo L, Bottasso BM, Coppola R, Fiorelli G, Mannucci PM (2000) Venous thromboembolism and hypercoagulability in splenectomized patients with thalassaemia intermedia. Br J Haematol 111:467–473CrossRefPubMed Cappellini MD, Robbiolo L, Bottasso BM, Coppola R, Fiorelli G, Mannucci PM (2000) Venous thromboembolism and hypercoagulability in splenectomized patients with thalassaemia intermedia. Br J Haematol 111:467–473CrossRefPubMed
5.
go back to reference Borgna Pignatti C, Carnelli V, Caruso V, Dore F, de Mattia D, di Palma A, di Gregorio F, Romeo MA, Longhi R, Mangiagli A, Melevendi C, Pizzarelli G, Musumeci S (1998) Thromboembolic events in beta thalassemia major: an Italian multicenter study. Acta Haematol 99:76–79CrossRefPubMed Borgna Pignatti C, Carnelli V, Caruso V, Dore F, de Mattia D, di Palma A, di Gregorio F, Romeo MA, Longhi R, Mangiagli A, Melevendi C, Pizzarelli G, Musumeci S (1998) Thromboembolic events in beta thalassemia major: an Italian multicenter study. Acta Haematol 99:76–79CrossRefPubMed
6.
go back to reference Taher A, Vichinsky E, Musallam K et al (2013) Guidelines for the management of non transfusion dependent thalassaemia (NTDT) Taher A, Vichinsky E, Musallam K et al (2013) Guidelines for the management of non transfusion dependent thalassaemia (NTDT)
7.
go back to reference Tripodi A, Cappellini MD, Chantarangkul V, Padovan L, Fasulo MR, Marcon A, Mannucci PM (2009) Hypercoagulability in splenectomized thalassemic patients detected by whole-blood thromboelastometry, but not by thrombin generation in platelet-poor plasma. Haematologica 94:1520–1527CrossRefPubMedPubMedCentral Tripodi A, Cappellini MD, Chantarangkul V, Padovan L, Fasulo MR, Marcon A, Mannucci PM (2009) Hypercoagulability in splenectomized thalassemic patients detected by whole-blood thromboelastometry, but not by thrombin generation in platelet-poor plasma. Haematologica 94:1520–1527CrossRefPubMedPubMedCentral
8.
go back to reference Tatli Gunes B, Turker M, Gozmen S et al (2014) Procoagulant phospholipid activity, whole blood thromboelastography and thrombin generation assay to detect hypercoagulability in thalassemic children. Blood 124:4896 Tatli Gunes B, Turker M, Gozmen S et al (2014) Procoagulant phospholipid activity, whole blood thromboelastography and thrombin generation assay to detect hypercoagulability in thalassemic children. Blood 124:4896
9.
go back to reference Chantarangkul V, Clerici M, Bressi C et al (2003) Thrombin generation assessed as endogenous thrombin potential in patients with hyper- or hypo-coagulability. Haematologica 88:547–554PubMed Chantarangkul V, Clerici M, Bressi C et al (2003) Thrombin generation assessed as endogenous thrombin potential in patients with hyper- or hypo-coagulability. Haematologica 88:547–554PubMed
10.
go back to reference Hemker HC, Al Dieri R, De Smedt E, Béguin S (2006) Thrombin generation, a function test of the haemostatic-thrombotic system. Thromb Haemost 96:553–561CrossRefPubMed Hemker HC, Al Dieri R, De Smedt E, Béguin S (2006) Thrombin generation, a function test of the haemostatic-thrombotic system. Thromb Haemost 96:553–561CrossRefPubMed
11.
go back to reference Garbowski MW, Carpenter J-P, Smith G, Roughton M, Alam MH, He T, Pennell DJ, Porter JB (2014) Biopsy-based calibration of T2* magnetic resonance for estimation of liver iron concentration and comparison with R2 Ferriscan. J Cardiovasc Magn Reson 16:40CrossRefPubMedPubMedCentral Garbowski MW, Carpenter J-P, Smith G, Roughton M, Alam MH, He T, Pennell DJ, Porter JB (2014) Biopsy-based calibration of T2* magnetic resonance for estimation of liver iron concentration and comparison with R2 Ferriscan. J Cardiovasc Magn Reson 16:40CrossRefPubMedPubMedCentral
12.
go back to reference Taher AT, Otrock ZK, Uthman I, Cappellini MD (2008) Thalassemia and hypercoagulability. Blood Rev 22:283–292CrossRefPubMed Taher AT, Otrock ZK, Uthman I, Cappellini MD (2008) Thalassemia and hypercoagulability. Blood Rev 22:283–292CrossRefPubMed
13.
14.
go back to reference Eldor A, Lellouche F, Goldfarb A et al (1991) In vivo platelet activation in beta-thalassemia major reflected by increased platelet-thromboxane urinary metabolites. Blood 77:1749–1753PubMed Eldor A, Lellouche F, Goldfarb A et al (1991) In vivo platelet activation in beta-thalassemia major reflected by increased platelet-thromboxane urinary metabolites. Blood 77:1749–1753PubMed
15.
16.
go back to reference Trinchero A, Marchetti M, Giaccherini C et al (2017) Platelet haemostatic properties in β-thalassaemia: the effect of blood transfusion. Blood Transfus 15:413–421PubMedPubMedCentral Trinchero A, Marchetti M, Giaccherini C et al (2017) Platelet haemostatic properties in β-thalassaemia: the effect of blood transfusion. Blood Transfus 15:413–421PubMedPubMedCentral
Metadata
Title
Role of platelets in thrombin generation amongst patients with non-transfusion-dependent thalassaemia
Authors
Chuen Wen Tan
Wan Hui Wong
Roserahayu Idros
Yiong Huak Chan
Hartirathpal Kaur
Alvin Ren Kwang Tng
Lai Heng Lee
Heng Joo Ng
Ai Leen Ang
Publication date
01-04-2019
Publisher
Springer Berlin Heidelberg
Published in
Annals of Hematology / Issue 4/2019
Print ISSN: 0939-5555
Electronic ISSN: 1432-0584
DOI
https://doi.org/10.1007/s00277-018-3579-z

Other articles of this Issue 4/2019

Annals of Hematology 4/2019 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.